| dc.contributor.author |
Wolf, Maija |
|
| dc.contributor.author |
Korja, Miikka |
|
| dc.contributor.author |
Karhu, Ritva |
|
| dc.contributor.author |
Edgren, Henrik |
|
| dc.contributor.author |
Kilpinen, Sami |
|
| dc.contributor.author |
Ojala, Kalle |
|
| dc.contributor.author |
Mousses, Spyro |
|
| dc.contributor.author |
Kallioniemi, Anne |
|
| dc.contributor.author |
Haapasalo, Hannu |
|
| dc.date.accessioned |
2010-12-08T13:59:00Z |
|
| dc.date.available |
2010-12-08T13:59:00Z |
|
| dc.date.issued |
2010 |
|
| dc.identifier.citation |
Wolf , M , Korja , M , Karhu , R , Edgren , H , Kilpinen , S , Ojala , K , Mousses , S , Kallioniemi , A & Haapasalo , H 2010 , ' Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication ' , BMC Cancer , vol. 10 , no. 181 , pp. - . https://doi.org/10.1186/1471-2407-10-181 |
|
| dc.identifier.other |
PURE: 9484021 |
|
| dc.identifier.other |
PURE UUID: 34ec285c-abd4-464c-9c35-3f876bdc5b4f |
|
| dc.identifier.other |
WOS: 000277804600001 |
|
| dc.identifier.other |
Scopus: 77951872238 |
|
| dc.identifier.other |
ORCID: /0000-0002-4463-6954/work/58742427 |
|
| dc.identifier.uri |
http://hdl.handle.net/10138/23854 |
|
| dc.description.abstract |
Neuroblastoma has successfully served as a model system for the identification of neuroectoderm-derived oncogenes. However, in spite of various efforts, only a few clinically useful prognostic markers have been found. Here, we present a framework, which integrates DNA, RNA and tissue data to identify and prioritize genetic events that represent clinically relevant new therapeutic targets and prognostic biomarkers for neuroblastoma. |
en |
| dc.format.extent |
13 |
|
| dc.language.iso |
eng |
|
| dc.relation.ispartof |
BMC Cancer |
|
| dc.rights.uri |
info:eu-repo/semantics/openAccess |
|
| dc.subject |
COMPARATIVE GENOMIC HYBRIDIZATION |
|
| dc.subject |
IN-SITU HYBRIDIZATION |
|
| dc.subject |
MYCN-AMPLIFICATION |
|
| dc.subject |
COPY NUMBER |
|
| dc.subject |
SMAC/DIABLO EXPRESSION |
|
| dc.subject |
OVEREXPRESSED GENES |
|
| dc.subject |
CERVICAL-CANCER |
|
| dc.subject |
DOWN-REGULATION |
|
| dc.subject |
DNA |
|
| dc.subject |
IDENTIFICATION |
|
| dc.subject |
318 Medical biotechnology |
|
| dc.title |
Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication |
en |
| dc.type |
Article |
|
| dc.contributor.organization |
Institute for Molecular Medicine Finland |
|
| dc.contributor.organization |
Neurokirurgian yksikkö |
|
| dc.description.reviewstatus |
Peer reviewed |
|
| dc.relation.doi |
https://doi.org/10.1186/1471-2407-10-181 |
|
| dc.relation.issn |
1471-2407 |
|
| dc.rights.accesslevel |
openAccess |
|
| dc.type.version |
publishedVersion |
|
